Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.


Investor type Venture Capital
Founders Trish Costello


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 148
Average round size
The average size of a deal this fund participated in
Portfolio companies 75
Rounds per year 14.80
Lead investments 0
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 4
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Medical Device
  • Biotechnology
  • Internet
  • Medical

Portfolia is the famous Corporate Investor, which was founded in 2012. The main office of represented Corporate Investor is situated in the Menlo Park. The company was established in North America in United States.

The high activity for fund was in 2018. The fund is generally included in 2-6 deals every year. The common things for fund are deals in the range of 5 - 10 millions dollars. When the investment is from Portfolia the average startup value is 50-100 millions dollars. This Portfolia works on 23 percentage points less the average amount of lead investments comparing to the other organizations.

The current fund was established by Trish Costello.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Portfolia, startups are often financed by GoBeyond, Astia Angels, Sand Hill Angels. The meaningful sponsors for the fund in investment in the same round are Astia Angels, iNovia Capital, Zelkova Ventures. In the next rounds fund is usually obtained by Uncork Capital, Golden Seeds, GoBeyond.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Personal Health, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Voxeet, Madorra, Envoy - The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Portfolia:
Typical Co-investors
Portfolia is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Portfolia:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
All American Properties -
Biodiscovery V -
Bow Wave Capital Management New York, New York, United States
Digital Health Ventures Berlin, Berlin, Germany
Dinglong Culture China, Guangdong Province, Shantou
Elastica California, Mountain View, United States
Hua Hsia Investment Holding Co Taipei, Taiwan
Intercorp Financial Services Lima, Lima, Peru
LMK Ventures -
Making Ideas Business Community of Madrid, Madrid, Spain
OPKO Health Florida, Miami, United States
Pioneers Ventures Austria, Linz, Oberosterreich
PoliHub Italy, Lombardia, Milano
Presbyterian Healthcare Services Clovis, New Mexico, United States
Reshape New York, New York, United States
Ridgeline Partners California, San Francisco, United States
Weijia Investment China, Ningbo, Zhejiang
Witruth Capital Beijing, Beijing, China
Wolf Family Trust Massachusetts, United States, Wayland
Zhejiang Meilin Venture Capital China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Secondary Education
$10M28 Dec 2022 Boston, Massachusetts, United States

Hey Jane

Health Care
Personal Health
$6M19 Oct 2022 New York, New York, United States


Retail Technology
$120M28 Sep 2022 San Francisco, California, United States

Inherent Biosciences

Health Care
05 Sep 2022 Salt Lake City, Utah, United States

Caban Systems

Clean Energy
Energy Storage
Renewable Energy
$51M22 Jul 2022 California, United States

Aria CV

Health Care
Medical Device
14 Jul 2022 Saint Paul, Minnesota, United States

Prime Genomics

Health Care
01 Jun 2022 Mountain View, California, United States


Artificial Intelligence
Health Care
Machine Learning
11 Apr 2022 California, United States


Retail Technology
$1M31 Mar 2022 San Francisco, California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Portfolia?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: